$ZWS

Contrasting Zurn Elkay Water Solutions Cor (NYSE:ZWS) & ARQ (NASDAQ:ARQ)

The article compares Zurn Elkay Water Solutions (NYSE:ZWS) and ARQ (NASDAQ:ARQ) across ownership, profitability, valuation, risk, and analyst views. It says ZWS has 83.3% institutional ownership vs ARQ’s 18.5%, while ARQ has higher beta (1.92 vs 1.11). MarketBeat consensus targets are $54.88 for ZWS and $7.50 for ARQ, with ARQ showing higher implied upside.

Original reporting
Published May 25, 2026, 2:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 25, 2026, 2:07 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Contrasting Zurn Elkay Water Solutions Cor (NYSE:ZWS) & ARQ (NASDAQ:ARQ) — source image
Decision brief

The 30-second read

$ZWSNeutralLow
01

Why it matters

Because no new company-specific news (earnings, deals, regulation, lawsuits, trials) is reported, the primary trading relevance is relative valuation/analyst-target positioning rather than a fresh fundamental catalyst.

02

Market read

Traders may use the article to compare relative risk/reward, but it lacks an explicit trigger for immediate repricing.

03

What to watch

High beta for ARQ (1.92) suggests drawdown risk; also, the article provides no detail on earnings revisions, backlog, or guidance changes that typically drive trading.

Relevance 5/10Timing: No specific event date; relevance is mainly for positioning based on relative valuation/targets.

Background

This is a comparative, metrics-based stock matchup (ownership, profitability, valuation, beta, and consensus price targets) between ZWS and ARQ.

Company-level read

Ticker impact

$ZWSNeutralMedium confidence
Context

Article compares ZWS vs ARQ on institutional ownership, profitability, valuation, beta, and a consensus price target of $54.88.

Expected impact

Limited near-term catalyst; any move likely follows broader sentiment toward water infrastructure/industrial plumbing names.

Evidence & confidence

No new ZWS-specific corporate action is reported; the only actionable inputs are comparative metrics and a stated consensus target.

$ARQBullishMedium confidence
Context

Article highlights ARQ’s lower P/E, higher beta, and a consensus price target of $7.50 implying upside of 204.88%.

Expected impact

Potential momentum bid if traders weight the large implied upside, but expect choppiness due to higher beta.

Evidence & confidence

Still no discrete ARQ catalyst is described; the trading signal is driven by comparative valuation and analyst target/upside framing.

Market effects

Read-across is limited because the two firms sit in different niches (water management products vs emissions/coal purification equipment).

None indicated; both are discussed at a company level without regional policy or demand shocks.

None indicated; no international regulatory or supply-chain event is cited.

Counterpoint

The ‘upside’ is derived from consensus targets in a comparison article, not from new fundamentals; large implied upside can reflect model optimism rather than imminent catalysts.

Key entities

  • Zurn Elkay Water Solutions Corporation

    Water management solutions provider; discussed via ownership/profitability/valuation/beta and a $54.88 consensus price target.

  • Arq, Inc.

    Environmental/emission control equipment holding company; discussed via lower P/E, higher beta, and a $7.50 consensus price target.

Related articles

$ZWSMed

Zurn Elkay Water Solutions Cor Q2 Earnings Call Highlights

Zurn Elkay Water Solutions (NYSE: ZWS) reported Q2 call highlights, including $48M cash from IEPA and reciprocal tariff refunds, with $60M remaining uncollected. Net debt leverage ended at 0.3x. It completed the $109M Intellihot acquisition, targeting $37M sales in 2026 and raised 2026 outlook: adj. EBITDA $503M-$513M and FCF at least $350M (excluding refunds).

$ZWSMed

ZWS: Record Q2 growth and margins, boosted by Intellihot acquisition and raised full-year outlook

Zurn Elkay Water Solutions (ZWS) reported Q2 2026 results with 10% organic sales growth and record EBITDA margins, citing strength in Water Safety, Drinking Water, and Flow Systems. The company said its Intellihot acquisition expands its addressable market. ZWS also raised its full-year guidance for sales, EBITDA, and free cash flow, according to its Q2 2026 transcript.

$ZWSMedAI 8/10

Zurn Water: Q2 Earnings Snapshot

Zurn Water Solutions (ZWS) reported Q2 profit of $113.3 million, or 67 cents per share. Adjusted earnings were 50 cents per share versus a Zacks/Wall Street estimate of 47 cents. Revenue was $491 million, above the $482.4 million expected by analysts surveyed by Zacks.

$ZWSMedAI 8/10

Zurn Elkay (NYSE:ZWS) Posts Better

Zurn Elkay (NYSE:ZWS) reported Q2 CY2026 results. Revenue rose 10.5% year on year to $491 million and exceeded Wall Street estimates by 1.6%. Non-GAAP profit was $0.50 per share, 5.8% above consensus. The company said it is raising its full-year outlook and repurchased $50 million of shares in the quarter.

$ZWSMed

Zurn Elkay Water Solutions Corp (ZWS): Results of Operations and Financial Condition

Zurn Elkay Water Solutions Corp (ZWS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991earningsrelease63026.htm EX-99.1 Document Exhibit 99.1 Press Release July 28, 2026 Contact Information: For Immediate Release Bobbi Belstner Vice President, Corporate Controller 414.361.0122 Zurn Elkay Water Solutions Reports Second Quarter 2026 Financial Results I